Minicircle Inc

EQO, Inc., based in Austin, TX, is a pioneering leader in the realm of whole ecosystem bio-monitoring and early-stage detection of Aquatic Invasive Species (AIS) using advanced environmental DNA (eDNA) and RNA technologies. Their innovative Osprey Survey System (O.S.S.) empowers clients to monitor water resources accurately and effectively, ensuring the protection of vital aquatic ecosystems. With a focus on actionable diagnostics and preventive measures, EQO provides a subscription service for their O.S.S., allowing for early detection and intervention in the fight against AIS infestations. The company's commitment to science-as-a-service enables clients to access comprehensive reports and tailored recommendations, ultimately safeguarding water resources from potential threats. Generated from the website

NanoMedical Systems, based in Austin, TX, specializes in developing innovative drug-delivery devices through its proprietary nStrada nanofluidics platform, which allows for sustained release of a diverse range of drugs and biologics. The company's nStrada implants offer long-term constant drug release without the initial burst often seen in traditional polymer-based systems, significantly improving patient care for chronic therapies. The nStrada platform employs advanced semiconductor manufacturing techniques and biocompatible materials, featuring a high-density array of nanochannels that precisely controls drug delivery. With proven in vitro and in vivo performance across multiple drug types and animal studies, NanoMedical Systems is at the forefront of revolutionizing drug delivery technology. Generated from the website

Onexio Biosystems LLC, located in Austin, TX, specializes in innovative microplate technology designed for co-culture applications that enhance assay relevance in high-throughput screening (HTS). Their flagship product, the microDUO, features patented micro-scale diffusion channels that facilitate drug metabolism and intercellular interactions in a user-friendly and cost-effective format. Co-founded by industry experts Tony Jimenez and Brian Johnson, Onexio aims to bridge the gap between traditional animal testing models and modern screening techniques. With a focus on developing physiologically relevant in vitro models, the microDUO platform supports intercellular signaling crucial for improving human relevance in drug discovery and chemical toxicity testing. Generated from the website